secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sunshine Biopharma Inc. (SBFM)
CIK:        0001402328
Form:       8-K
Filed at:   2023-10-13T23:59:59+00:00
Accession:  0001683168-23-007129
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Sunshine Biopharma warrant holders approve amendment reducing exercise price to $0.11
--------------------------------------------------------------------------------

- Warrant holders approved amendment to reduce Tradeable Warrants exercise price to $0.11.
- 736,242 warrants voted in favor (76.4% of 963,693 outstanding), 62,429 against, 3,930 abstentions.
- Amendment also eliminates restriction on CEO Steve Slilaty's voting rights under Series B Preferred Stock.
- Special meeting of warrant holders held on October 12, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1402328/000168316823007129/0001683168-23-007129-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1402328/000168316823007129/sunshine_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-23-007129

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer